ALNUCTAMAB
UNII 7OSV6M6T4D

Substance Identification & Data

This profile provides standardized clinical and technical data for Alnuctamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7OSV6M6T4D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2296827-07-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7OSV6M6T4D
CAS Registry Number
2296827-07-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ALNUCTAMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C175740
National Cancer Institute reference terminology for clinical and research data.
INN ID
11457
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
GH-171
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Alnuctamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ALNUCTAMAB

Common Names & Synonyms

ALNUCTAMAB [INN]
ALNUCTAMAB [USAN]
ALNUCTAMAB [WHO-DD]
IMMUNOGLOBULIN G1-KAPPA/LAMBDA WITH DOMAIN CROSSOVER, ANTI-(HOMO SAPIENS TNFRSF17 (TNF RECEPTOR SUPERFAMILY MEMBER 17, TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 17, B CELL MATURATION ANTIGEN, BCMA, BCM, TNFRSF13A, CD269)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), MONOCLONAL ANTIBODY, BISPECIFIC, TRIVALENT

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus